A phase II study of durvalumab, doxorubicin, and ifosfamide in recurrent and/or metastatic pulmonary sarcomatoid carcinoma (KCSG LU-19-24).
  • Keam, Bhumsuk
  • Youk, Jeonghwan
  • Kim, Tae Min
  • Lee, Gyeong-Won
  • Kim, Dong-Wan
  • 외 1명
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0
제목
A phase II study of durvalumab, doxorubicin, and ifosfamide in recurrent and/or metastatic pulmonary sarcomatoid carcinoma (KCSG LU-19-24).
저자
Keam, BhumsukYouk, JeonghwanKim, Tae MinLee, Gyeong-WonKim, Dong-WanKim, Miso
DOI
10.1200/JCO.2025.43.16_suppl.8566
발행일
2025-06
유형
Meeting Abstract
저널명
Journal of Clinical Oncology
43
16_SUPPL